Yakutia's Cardiovascular Center cuts heart attack deaths by 36% in 2025
Yakutia's Cardiovascular Center cuts heart attack deaths by 36% in 2025
Yakutia's Cardiovascular Center cuts heart attack deaths by 36% in 2025
Yakutia's Cardiovascular Center has made significant progress in reducing heart and stroke-related deaths. In 2025, mortality from acute myocardial infarction dropped by 36%, while deaths from cerebrovascular accidents fell by 24%. The facility has treated thousands since opening its doors. The centre operates with 17 specialised departments, offering round-the-clock care. Since its launch, over 20,000 residents have received inpatient treatment, while 58,000 have undergone outpatient examinations.
Its total capacity includes 50 cardiology beds, 46 cardiac surgery beds, and 39 neurology beds. For recovery, 15 rehabilitation beds are available, alongside 25 intensive care units.
The improvements in survival rates reflect the centre's expanded services and specialised care. Both heart attack and stroke patients now benefit from more timely and effective interventions. The centre's impact is clear in the declining death rates for major cardiovascular conditions. With thousands treated and mortality figures falling, the facility continues to strengthen healthcare in the region. Further data on long-term outcomes may provide additional insights in the future.
Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
A revolutionary approach to clearing stubborn arterial deposits could transform PAOD care. Free screenings and lab tours bring cutting-edge vascular medicine to the public.
Russian schoolchildren's chronic illnesses triple by graduation, study reveals
From first grade to graduation, their health declines sharply. Experts warn of a crisis in vision, digestion, and mental well-being among young learners.
RHÖN-KLINIKUM AG reports 6.8% revenue growth despite profit dip in 2025
Germany's leading hospital group balances growth with innovation—yet faces profit challenges. How will its €0.20 dividend and tech investments shape 2026?
Sanuwave Health reports 35% revenue surge in 2025 with record UltraMist sales
A breakthrough year for Sanuwave: profits and demand skyrocket. How UltraMist systems drove a 30% Q4 sales leap and reshaped the company's financial future.